Big Rise Is Predicted In Biotech Job Market

The results of the employment survey come from Mark Dibner, director of the North Carolina Bio- technology Center in Research Triangle Park. Dibner’s study confirmed that most of the companies surveyed had started small— averaging only 13 employees by the end of their first year. Most, however, showed significant growth, with one firm mushrooming to 160 employees by the end of its first year. On average, the companies surveyed had 86 employees after six years. The center’s


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The results of the employment survey come from Mark Dibner, director of the North Carolina Bio- technology Center in Research Triangle Park. Dibner’s study confirmed that most of the companies surveyed had started small— averaging only 13 employees by the end of their first year. Most, however, showed significant growth, with one firm mushrooming to 160 employees by the end of its first year. On average, the companies surveyed had 86 employees after six years.

The center’s questionnaire then asked the biotech company managers to project what their staff levels would be five years from now. According to the responses, the firms’ staffs are expected to grow by 27% annually, with the average soaring from the 86-employee average now to well over 200 five years from now.

Dibner says that as this growth progresses, the kind of jobs available in the biotech industry will change. He found that production and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development